Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

kbiosystems Ltd UK Custom Project Division See Sharp Increase in Business

Published: Thursday, January 02, 2014
Last Updated: Thursday, January 02, 2014
Bookmark and Share
Company has seen an increase in the number of custom automation projects globally with the added benefit of entering in to new market sectors.

John Woodford, Director of kbiosystems Ltd, who is spearheading the changes, commented “Over the last few years our business has grown and the markets we now serve have. We continue to provide standard products for the Life Sciences industry with some exciting new products due for launch in 2014, our custom project division are working in differing industries to those we did in the past. These industries include Biofuels, Diagnostics and the Optical Lens production, third party OEM and full production automation both large and small”.

Although the projects worked on have all been under non-disclosure agreements, the diversity of requirements highlights the expertise kbiosystems Ltd have in house to adapt to the ever changing needs of the clients.

John Woodford, who heads up this division and part owner of kbiosystems Ltd says “Our key strength is the ability to take a concept from our clients and provide them with a detailed plan of the end product designed from our own design department. With a manufacturing workshop, having recently had a £250,000 investment, we are able to provide our clients with a solution that exceeds their expectations”. He adds “We pride ourselves on designing and engineering solutions that are robust and stand the test of time. Many products are still working from our early days. The after sales care is second to none and believe in building long lasting relationships with customers that culminates in repeat and referred business”.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos